Labcorp Holdings stock snapshot Labcorp Holdings (LH) stock has been moving without a clear single catalyst, which leads many investors to focus on its fundamentals, including recent returns, revenue, ...

Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting ...

The trial will assess if direct outreach by healthcare providers increases cascade genetic testing among first-degree ...

As healthcare becomes increasingly consumer-driven, individuals are turning to AI tools to help interpret health information, from understanding lab results to determining next steps in care.

Investors might want to bet on Labcorp Holdings (LH), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...

The big new thing in medtech for 2026 is AI-powered apps and chatbots designed to help patients navigate their laboratory test results. Now, testing giant Labcorp is getting in on the act. The company ...

Medical testing giant LabCorp is still recovering from a ransomware attack nearly a week later, but won’t say just how the hackers got in nor how many servers were impacted. LabCorp was forced to shut ...

Labcorp’s testing capabilities are getting a little broader with the $237.5 million acquisition of certain laboratory assets from BioReference Health, a subsidiary of Opko Health. The BioReference ...

Labcorp is a global life sciences company headquartered in Burlington, North Carolina. Labcorp provides at-home test kits as well as in-person testing at their laboratory facilities, which are located ...

The deal includes outreach laboratory services in 13 states. CHS will continue to operate its inpatient and emergency department labs along with other hospital-based testing services. Like its chief ...

This was the stock's second consecutive day of losses.